Background: Occult Hepatitis B virus infection (OBI) among blood donors is an important medical concern.
Introduction:
The safety of blood in blood bank is an important global issue, as blood transfusion is a vital therapeutic procedure (1) ; the prevention of pathogen transmission through blood transfusion is a challenging subject. The presence of new cases of hepatitis B virus infections is continue to occur despite screening testing of HBV using HBs Ag with highly sensitive and specific techniques (2) . Many blood banks have added antibodies specific to Hepatitis B core antigen (anti-HBc Abs) as a second HBV marker for detection HBV infections (3) . The presence of anti-HBc Abs in absence of HBs Ag positivity has two scenarios: either blood donor was infected and now cured from infection or the donor is still infected and the infection can be elucidated by viral nucleic acid amplification technique (4) . The Blood donor with serological evidence of negative HBs Ag, positive or negative HBc Abs, and positive HBV nucleic acid is known as occult HBV infection (5, 6) . This infection is a hidden source of HBV transmission, not only through blood in blood bank, but also to families of infected patients. This study was conducted to detect the prevalence of 
Methodology:
During a period of three months (from January till March 2017), volunteer blood donors in Hawler Major Blood Bank were routinely tested for HBs Ag by ELISA technique (HBsAg/Biorad/France) and total anti-HBc Abs using ELISA technique (Total Anti-HBc Abs/Biorad/ France); donors with negative HBs Ag and positive total anti-HBc Abs were our target study population and blood samples were aspirated from two hundred and seventy six (n=276) donors with HBsAg-/HBcAb+. Written informed consent was obtained from blood donors with HBsAg-/HBcAb+ who accepted participation in the study. The aspirated blood from each donor in the study group was centrifuged and each serum sample was divided into four aliquots of 1.5 ml tubes then stored in deep freeze (-70ºC Demographic and clinical data were gathered from each participant in the study. The results were analyzed using SPSS program.
Results:
A total number of 12,185 blood donations were screened for hepatitis B virus infection using two serological markers: HBsAg and total anti-HBcAb. The combination of positive HBsAg and anti-HBc Abs were found in 27 donors, while 276 donors were HBsAg-/anti-HBcAb+. The prevalence of HBV infection among blood donors during the period of sample collection was 2.49%, and the prevalence of HBs Ag -/ HBc Ab+ was 2.27%, while the prevalence of positive HBsAg was 0.22%. Two molecular techniques, quantitative and qualitative PCR techniques, were used for detecting HBV nucleic acid in HBs Ag-/HBc Abs+ blood donors and the results showed that 39.1% (108/276) of them were positive for HBV in real time-PCR, while 37% were positive in qualitative (conventional) PCR, the differences were statistically not significant (table  1) . Depending on RT-PCR results of HBV load, the prevalence of OBI among blood donors in Hawler Major Blood Bank was 0.09%, and the prevalence of OBI among HBs Ag -/HBc Ab + was 39.1%. For the 108 positive HBV load by Real time-PCR, the mean of the HBV PCR viral load is 11996 copies/ml, the median is 89.5copies/ml, and the range is 19-308000 copies/ml. The mean age of OBI was 42.72 ±10.988; most of blood donors in study group were males 273 (98.91%), while only 3 (1.09%) were females, and all OBI were males. Most of HBsAg-/HBcAb+ blood donors were having blood group O+, while the other blood groups in descending sequence were B+, A+, O-, A-, AB+, and AB-(table 2). None of the OBI donors was B-, or AB-, and most of them were O+ and the overall differences in blood groups between OBI donors and other donors with negative HBV nucleic acid was statistically not significant p ˃ 0.05, figure (1). Concerning the occupation of blood donors of both groups, OBI group (n=108) and negative HBV DNA group (n=168), most of them were working in free business and employees, while few of them retired or unemployed, and no significant statistical differences were present in professions of all HBsAg-/HBcAb+, figure (2). The significance of differences in clinical data between OBI group (n=108) and negative HBV DNA (n=168) showed that donation and receiving of blood, history of contact with HBV infected persons, history of surgical operations, and history of jaundice were not statistically significant while history of chronic diseases and History of tattooing or skin piercing were statistically significant, table 
Discussion:
The occult HBV infected blood donors can transmit infection to others. The absence of HBs Ag and the persistence of HBV nucleic acid in the blood or in hepatocytes is the hallmark of occult HBV. The prevalence of positive HBs Ag among blood donors in this study is much lower than the corresponding HBV marker in most regions of Iraq, for example in Duhok it is 0.78% (7), in Baghdad it is 0.6% (8), in Babylon governorate 0.7% (9), in Najaf governorate 0.66%, and 3.5%in Karbala (10), the prevalence of HBs Ag was higher than the that recorded in Basra, 0.02% (11) . The HBs Ag was also screened in neighboring countries, in Kuwait, in 2002, it was 1.1% among Kuwaiti blood donors (12); in Jordan, it was 1.4% (13) , while in Denizli, Turkey it was 0.97% (14). The prevalence of HBV infection in the current study was 2.49%, which is close to that recorded among blood donors ( 2.3%) in Basra in2013 (11) , but less than a study in Erode District, India which recorded a prevalence of 10.9% (15 (27) , 38 % in Japan (28) and 90.5 % in Sudan (29) . In the current study the mean and median of HBV DNA load among OBI were low, 11996 copies/ml and 89.5 copies/ml respectively, these results are in accordance to results of Ye X, et al (30) and to the general impression that OBI is characterized by very low HBV DNA load (31). In this study, most of OBI are in their 5 th decade of age and are male gender, and most of clinical and demographic data, with the exception of history of chronic diseases, are not significant risk factors for the development of OBI and HBsAg-/HBcAb+. While a study by Said ZN et al demonstrated that age of OBI is mostly below thirty (32). The Concentration of DNA yield from viral DNA extraction has no correlation with the HBV load, this is an interesting finding which might be due to other nonspecific viral nucleic acids extracted which are not amplified by HBV amplification PCR kit. 
Conclusions

